Back

Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)

27 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathies in myocardial disease Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Neal Lakdawala

Brigham and Women's Hospital, Boston (United States of America)

7 More presentations in this session

Presentation thumbnail
Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial
Doctor H. Procter (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up
Doctor M. Schiavo (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy
Doctor E. Maksabedian Hernandez (Princeton, US)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic evolution in Anderson-Fabry disease: a valuable tool to detect progressive cardiac involvement
Doctor R. Baldassarre (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Ultrastructural myocardial changes in patients with severe aortic stenosis referred for surgical aortic valve replacement
Doctor R. Reis Santos (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathies in myocardial disease

The Event

Event poster

ESC Congress 2023

27 August 2023 17:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources